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Abstract
Background: Assessment of gene expression is an important component of osteoarthritis (OA)
research, greatly improved by the development of quantitative real-time PCR (qPCR). This
technique requires normalization for precise results, yet no suitable reference genes have been
identified in human articular cartilage. We have examined ten well-known reference genes to
determine the most adequate for this application.
Results: Analyses of expression stability in cartilage from 10 patients with hip OA, 8 patients with
knee OA and 10 controls without OA were done with classical statistical tests and the software
programs geNorm and NormFinder. Results from the three methods of analysis were broadly
concordant. Some of the commonly used reference genes, GAPDH, ACTB and 18S RNA,
performed poorly in our analysis. In contrast, the rarely used TBP, RPL13A and B2M genes were
the best. It was necessary to use together several of these three genes to obtain the best results.
The specific combination depended, to some extent, on the type of samples being compared.
Conclusion: Our results provide a satisfactory set of previously unused reference genes for qPCR
in hip and knee OA This confirms the need to evaluate the suitability of reference genes in every
tissue and experimental situation before starting the quantitative assessment of gene expression by
qPCR.
Background
Osteoarthritis (OA) is the most common rheumatic dis-
ease and a leading cause of disability in the elderly [1]. It
involves ligaments, subchondral bone, synovium and car-
tilage [2,3]. Most research in OA has been focused in artic-
ular cartilage where the disease becomes highly evident in
its late stages. Biochemical changes in chondrocytes and
extracellular matrix components are followed by macro-
scopic lesions including thinning, fibrillation, fissuring
and erosion of cartilage that will eventually lead to denu-
dation of subchondral bone. These changes result from
active processes that involve matrix destruction and inef-
ficient repair [4-6]. Progress in the management of OA
requires better knowledge of the regulation of these proc-
esses as they could have a different impact depending on
its etiology. The commonest form of OA is idiopathic and
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appears only in the elderly. Nevertheless, some forms of
OA have a genetic cause or are secondary to rheumatic,
endocrine, metabolic or neuropathic diseases or to local
factors like trauma, infection or avascular necrosis [7].
This variety of etiologies as well as OA chronic evolution,
its heterogeneity in different joints, and the possibility of
wide differences in gene expression between different dis-
ease stages or areas of cartilage complicate OA research [8-
10]. There are not generally accepted methods to address
these issues.
In recent years, it has become possible to study satisfacto-
rily gene expression in cartilage. A major problem has
been the difficulty in obtaining RNA due to the unique
characteristics of human cartilage as low cell content, col-
lagenous matrix and richness in proteoglycans that co-
purify with RNA [11]. Methods improving RNA yield and
quality as well as methods of cDNA amplification by in
vitro transcription that can compensate for the poor con-
tent of RNA in human cartilage have been reported [11-
14]. Techniques allowing precise quantification of gene
expression are also available, microarrays for a large
number of genes or quantitative real-time PCR (qPCR) for
individual genes [5,9,10,15-18] This latter has a main role
in studies focused on a few genes and to validate results
from microarray studies. However, the full potential of
qPCR cannot be obtained if specific care is not taken
[19,20].
The absolute amount of a gene RNA can be quantified by
qPCR, but this is seldom done because between-sample
variation in RNA extraction, reverse transcription and PCR
efficiency make the procedure inaccurate. Also, require-
ment of gene-specific calibration curves makes it too com-
plex for many laboratories [20,21]. The commonest
alternative is relative quantification, in which normaliza-
tion by endogenous reference genes allows comparison
between samples but not between genes. In this approach,
selection of the reference gene is critical because its expres-
sion should be invariable under the conditions of study
[22-25]. The suitability of reference genes in cartilage has
not been addressed previously, though a study on
chondrocytes has recently been published [26], and this
lack of analysis is not without risks. Most reference genes
in common use were selected because they are housekeep-
ing genes, that is, they are widely and constitutively
expressed in many tissues and stages of development.
However, these genes are also regulated [21]. They were
useful for Northern blot and RNase protection assays but
not for the more sensitive real-time qPCR. Small changes
in expression of the reference genes will lead to wrong
conclusions, as has been shown in many areas of research
[25,27-29]. Therefore, expression stability of the prospec-
tive reference genes should be explored in each specific tis-
sue and type of experiment [22,30,31]. In fact, most
authors that have investigated this area agree in the need
of using more than a single reference gene to obtain high
quality data [30,32]. In our study, we have explored ten
well-known reference genes to identify the most suitable
for normalization of qPCR data from human cartilage
obtained from the hips and knees of elderly healthy sub-
jects and OA patients.
Results
The prospective reference genes included in this study cov-
ered a wide range of expression levels in articular cartilage
(mean Ct values ranging from 18 to 36). Results from
individual samples showed a uniform dispersion around
the mean without any marked skeewing (not shown).
qPCR replicates showed very low variability, with a mean
coefficient of variation (CV) of 1.08% ± 1.2 (standard
deviation, SD). When the raw individual values were strat-
ified by group of samples-hip OA, knee OA, or hip con-
trols – there were differences in the HPRT1 and 18S RNA
values. After data transformation, which involved correc-
tion by well-specific efficiency and determination of the
relative value of each sample in relation to the gene-spe-
cific median of all samples, the Mann-Whitney U test
showed that 18S RNA was expressed at significantly lower
levels in hip and knee OA cartilage than in control hip car-
tilage (p = 0.03). This difference indicated a possible
source of spurious results if 18S RNA is used for normali-
zation in qPCR across the mentioned groups of samples.
Transformed expression data were further analyzed with
the geNorm software that determines a gene expression
stability measure (M) for each candidate reference gene
based on the average pairwise variation between a partic-
ular gene and all other control genes [30]. For this analy-
sis, results from the 28 samples were considered together.
As shown in Figure 1, the least stable gene with this
approach was HPRT1 and the most stable genes were
RPL13A and TBP. All the others were between them with-
out discernible groups among them. The same software
provides an estimation of the optimum number of refer-
ence genes. This estimation is obtained by analysis of the
changes in the normalization factors obtained by adding
successively the next most stable gene of the set. A large
change after a step indicates that the added gene has a sig-
nificant effect and should be included in the normaliza-
tion factor. Changes in our data set were rather uniform
(Figure 2) with a possible optimum point after including
the four most stable genes: TBP, RPL13A, B2M and 18S
RNA.
We were concerned by the possibility that sex differences
between control and OA samples could affect the choice
of most stable genes. However, separate geNorm analyses
in men and women provided the same set of three most
stable genes, TBP, RPL13A and B2M. The geNorm analysisBMC Molecular Biology 2008, 9:17 http://www.biomedcentral.com/1471-2199/9/17
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was also repeated after excluding the HPRT1 and 18S RNA
genes given the mentioned differences in expression
between groups of samples. In this new analysis, the most
stable genes were RPL13A and TBP, followed by B2M,
concordant with the previously found.
Given the distribution of our samples in three clinically
different groups, it was interesting to analyse qPCR data
with the NormFinder program that provides a stability
value considering sample stratification in groups [32]. The
best two-gene combination considering the three groups
of samples (hip OA, hip controls and knee OA), was TBP
and RPL13A, corresponding to the geNorm result. A gen-
eral concordance was also found when considering the
results of each gene individually (Figure 3). There were the
same less stable genes including GAPDH, HPRT1, HMBS,
UBC and SDHA and the same most stable genes including
TBP, RPL13A, B2M, 18S RNA and ACTB. We have also
explored how the stability values changed if the samples
were considered in groups that could be clinically rele-
vant: hip OA vs hip control samples, hip OA and knee OA
together vs hip controls, and hip OA vs knee OA. In all
these comparisons, the genes with the most stable expres-
sion were RPL13A, TBP, B2M, ACTB and 18S RNA, with
their order changing slightly in function of the groups
considered (Figure 3).
Discussion
A first consideration in the analysis of our results is that
the prospective reference genes that we have analyzed had
already been selected in previous studies because of their
utility for this function [25,28,30,32], they have relative
stable expression and we did not expect large differences
between them. Also, these genes are from different func-
tional families and not known to be coregulated. This
Stability of the prospective reference genes depending on the  way the samples were grouped Figure 3
Stability of the prospective reference genes depend-
ing on the way the samples were grouped. The stability 
values, V, were obtained with NormFinder that combines 
intra- and intergroup variation in the expression of each 
gene. Results from all the meaningful comparisons of samples 
from the Hip OA, Knee OA and Hip Control groups are pre-
sented. Lower values of V correspond to the most stable 
genes, hence the most appropriate for normalization.
TBP RPL13A B2M 18S ACTB SDHA UBC HMBS GAPD HPRT1
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
S
t
a
b
i
l
i
t
y
,
 
V
 3 groups
 Hip+Knee OA vs Hip control
 Hip OA vs Hip control
 Hip OA vs Knee OA
Average expression stability, M, of prospective reference  genes Figure 1
Average expression stability, M, of prospective refer-
ence genes. Values of M were obtained with the geNorm 
software that compares gene expression without accounting 
for experimental groups and proceeds to the stepwise exclu-
sion of the genes whose relative expression levels are more 
variable among tissue samples. Lower values of M corre-
spond to the most stable genes, hence the most suitable for 
normalization.
HPRT1
GAPDH
UBC
HMBS
SDHA
ACTB
18S
B2M
RPL13A TBP
0.6
0.7
0.8
0.9
1.0
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1.9
A
v
e
r
a
g
e
 
s
t
a
b
i
l
i
t
y
,
 
M
 
Evaluation of the optimum number of reference genes  according to the geNorm software Figure 2
Evaluation of the optimum number of reference 
genes according to the geNorm software. The magni-
tude of the change in the normalization factor after the 
inclussion of an additional reference gene reflects the 
improvement obtained. Vi/i+1 represent the models being 
compared: those with i and i+1 reference genes.
0.287
0.242
0.212
0.253
0.236
0.221
0.235
0.205
V2/3 V3/4 V4/5 V5/6 V6/7 V7/8 V8/9 V9/10
0.0
0.1
0.2
0.3
C
h
a
n
g
e
 
i
n
 
N
o
r
m
a
l
i
z
a
t
i
o
n
 
F
a
c
t
o
rBMC Molecular Biology 2008, 9:17 http://www.biomedcentral.com/1471-2199/9/17
Page 4 of 7
(page number not for citation purposes)
implies that each one provides independent and comple-
mentary information, which is an important requisite for
geNorm analysis. A second important consideration is
that we have made efforts to minimize every known
source of experimental variation by DNAse digestion,
adjusting the amount of input RNA, using two-step
reverse transcription polymerase chain reaction (RT-PCR)
and by correcting raw results for PCR efficiency [19-
21,24,33]. These steps are a requisite for the assumption
that observed results reflect true gene expression. We
found specially necessary to include a DNAse digestion
step because human genome has many processed pseudo-
genes inserted by retrotransposition that are amplified in
PCR even with intron-spanning primers [30].
The systematic selection of the best reference genes for
real-time qPCR has been approached with different meth-
ods. All of them look for stability of the expression levels,
by either absence of differences between clinically rele-
vant groups [28], or relative stability in relation to other
reference genes [30,34] or in relation to clinically relevant
groups [32]. These analyses have been facilitated by the
free availability of programs and by the description of
their principles and use [30,32,34]. There are no definitive
reasons to prefer one method over the others as their rel-
ative strengths depend on the circumstances and we have
used three of the best-grounded: a conventional statistical
test to compare clinically relevant groups and the geNorm
and NormFinder softwares. Results from the three were
broadly similar, though the conventional statistical analy-
sis lacked sensitivity. The independence of our results
from the analysis method gives credence to the conclu-
sions.
The most striking result was the poor performance of
some commonly used reference genes. A special case was
GAPDH that is widely used in many areas of research [22]
and is one of the best reference genes in many tissues [30].
Nevertheless, there have been also previous examples of
this gene leading to wrong results due to its lack of stabil-
ity in specific experimental conditions [22]. In our study,
GAPDH was not among the best reference genes in any of
the analyses done. Other two commonly used reference
genes, ACTB and 18S RNA [22], performed better in our
tests but they were not among the more stable genes in
most comparisons. These results confirm, once more, the
need to evaluate the reference genes in each experimental
setting. A particularly striking example in this regard, is
the contrast between our results and the reported in pros-
tate cancer tissue, where HPRT1 was the most stable gene,
and RPL13A and ACTB were the most unstable [28]. In
our experiments, their ranks were reversed, i.e. HPRT1 was
the most unstable and RPL13A one of the most stable
genes.
Best reference genes in articular cartilage from elderly sub-
jects were among the less commonly used: TBP, RPL13A
and B2M. Best results will be obtained by combining two
or three reference genes as emphasized by several authors
[30,32]. We propose that for general studies of cartilage
from elderly subjects a combination of TBP and RPL13A
could be a good starting point, with the inclusion of B2M
if practical. For specific comparisons other combinations
could be more appropriate.
Finally, it is necessary to take into account some limita-
tions of our study. First, we have included a limited array
of prospective reference genes. Other genes have been pro-
posed for use in qPCR, and it is possible that some of
them are better candidates for articular cartilage studies in
elderly subjects. Microarray data from cartilage, that now
start to be published [5,10] will provide clues for the iden-
tification of the best candidates. Second, our results only
apply directly to articular cartilage with a focus in OA of
large joints. In particular, collection of samples from sur-
gical procedures dictated that all donors were older than
60 years and that OA samples were of an advanced disease
stage. This mimics most of the studies in cartilage in OA.
However, it is unclear how well our results could be
extended to other joint areas, patients with different ages
or OA at early stages. Nevertheless, our study can serve as
a guide for any kind of cartilage study, and reference genes
could be used once tested for low M values. It is also
unclear to what extent results obtained with SYBR Green
quantification will be applicable to other relative qPCR
techniques.
Conclusion
Precise assessment of gene expression in cartilage samples
from elderly subjects requires selection of suitable refer-
ence genes. Some of the commonly used performed
poorly, questioning the accuracy of previous reports.
Combinations of the previously unused genes TBP,
RPL13A and B2M were found to perform addequately and
are recommended to improve evaluation of gene expres-
sion in OA research. In studies involving only the hip
joint, TBP and RPL13A are the best choice.
Methods
Cartilage samples
Human articular cartilage was obtained from femoral
heads and from the femoral condyles and tibial plateaux
of patients undergoing total joint replacement surgery at
the Hospital Provincial de Conxo (Santiago de Compost-
ela, Spain). Causes of joint replacement were primary OA
or fracture of the femoral neck. All subjects have been
already diagnosed by the clinicians following them from
anamnesis, and clinical and radiographic data. One of us,
a licensed rheumatologist, reviewed all this previous
information including the radiographs previous to jointBMC Molecular Biology 2008, 9:17 http://www.biomedcentral.com/1471-2199/9/17
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surgery. He also conducted a new anamnesis of each sub-
ject following a specific questionnaire and performed a
new clinical evaluation when possible (not yet operated).
Confirmation of diagnosis was made at the time of joint
removal based on macroscopic findings. No histology
examination was done. The fracture patients were selected
to exclude history of joint disease, and radiographic and
macroscopic signs of joint lesions. No patients with
unclear classification as either OA or non-OA were
included. After selection with these criteria, 10 hip OA, 8
knee OA and 10 hip fracture samples, age- and sex-
adjusted, were used. No knee control samples were avail-
able for study. Main characteristics of the cartilage donors
are shown in Table 1. This study received the approval of
the Ethical Committee for Clinical Research of Galicia and
all participants gave their written informed consent. All
participants were of Spanish ancestry.
Cartilage dissection and evaluation
Intact femoral heads and knees were washed and kept in
sterile PBS at 4°C. Surface of the cartilage was carefully
examined and graded by the macroscopic visual Collins'
scale modified by Muehleman [35]. Briefly, grade 0: no
signs of cartilage lesions; grade 1: very limited disruptions
of the articular surface with no changes in surface geome-
try; grade 2: deep fibrillation and fissuring, early marginal
hyperplasia and possibly, small osteophytes; grade 3:
extensive fibrillation and fissuring, 30% or less of the
articular cartilage surface eroded down to the subchondral
bone, and osteophytes; and grade 4: lips or shelves at the
articular margin, greater than 30% of the articular surface
eroded down to the subchondral bone and gross geomet-
ric changes and osteophytes. Cartilages with Collins
grades 0 and 1 are considered normal, while cartilages of
grade 2 and higher are considered degenerated. Given the
advanced stage of disease in the OA samples there were
areas of the joint surface without cartilage. All the remain-
ing cartilage was removed from the bone using a scalpel,
chopped into 2–5 mm pieces and snap-frozen in liquid
nitrogen within 6 hours of surgery. For consistency, we
took also all available cartilage from control donors. Spe-
cial care was taken to exclude fibrotic tissue or any
subchondral bone contamination. Tissue pieces were
stored at -80°C until further processing.
RNA extractions
RNA extractions from articular cartilage were performed
following the method of Price et al [12] with the addition
of a DNase digestion step. Frozen cartilage was weighed
and 1 g was ground using a stainless-steel mortar and pes-
tle that were liquid nitrogen-cooled. After initial extrac-
tion in TRI Reagent (Sigma, Saint Louis, MO), the
aqueous phase was mixed with a half volume of 100%
ethanol and further purified on silica-gel-based mem-
branes using the RNeasy Plant Mini Kit (Qiagen, Valencia,
CA) according to the manufacturer's instructions. A
DNase I (Qiagen, Valencia, CA) digestion step was per-
formed on the spin column. Concentration of the isolated
RNA and the 260/280 nm absorbance ratio were meas-
ured with the NanoDrop® ND-1000 spectrophotometer
(NanoDrop Technologies, Wilmington, DE, USA). Sam-
ples with 260/280 ratio < 1.90 were discarded.
RT-QPCR
RNA was reverse transcribed to cDNA using Transcriptor
Reverse Transcriptase (Roche Applied Science, Barcelone,
Spain) and random hexamers in a total volume of 20 μl
according to the manufacturer's instructions. Limited
RNA quantities dictated input RNA amounts to be 220 ng.
Complementary DNA was stored at -20°C until 0.5 μl
were used in each downstream PCR. Oligonuleotide
primers were designed using Primer3 software [36] in dif-
ferent exons to help prevent amplification of genomic
DNA. PCRs were performed using DyNAmo™ SYBR®
Green qPCR kit (Finnzymes, Espoo, Finland) and
Chromo4™ real-time PCR detection system (MJ Research,
Basel, Switzerland). The PCR reaction volume was 10 μl
with 0.1 μM of the primers. Cycle conditions were set as
an initial denaturation step for 10 min at 95°C, followed
by 40 cycles of 10 s at 94°C for template denaturation, 15
s for annealing and 10 s at 72°C for extension. Table 2
shows the annealing temperatures and the MgCl2 concen-
trations specific for each set of primers. All reactions were
run in duplicate and all samples were analyzed in the
same run to exclude between-run variations. Each RNA
sample was controlled for genomic DNA contamination
for each gene-specific PCR by a reaction well without
reverse transcription. Reagent contamination was also
examined by a reaction mix without template. Specificity
of the PCR reactions was confirmed by melting curve anal-
ysis of the products as well as by size verification by DNA
electrophoresis in agarose gels.
PCR efficiency and Cycle threshold (Ct) determination
PCR efficiency was calculated with the LinRegPCR pro-
gram [33] from raw fluorescence data taken from the
Chromo4™ real-time PCR detection system. According
with this method PCR efficiency is the slope of the straight
line that best fit the log-linear part of the amplification
curve. Mean efficiencies were determined in sample dupli-
Table 1: Characteristics of the cartilage donors included in the 
study
Group
Parameter Knee OA Hip OA Hip control
No. of patients 8 10 10
Age, median (range) years 72 (67–77) 75 (66–85) 81 (72–91)
No. male/female 5/3 5/5 3/7
Collins grade, average (range) 3.4 (2–4) 3.7 (2–4) 0.7 (0–1)BMC Molecular Biology 2008, 9:17 http://www.biomedcentral.com/1471-2199/9/17
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cates and used to adjust Ct values. Ct values, the cycle
number at which the fluorescence signal of the sample
exceeds background fluorescence, were used for the quan-
titative comparison of the amplification rates. They were
obtained using Opticon Monitor™ version 3.0 software,
provided with the Chromo4™ real-time PCR detection sys-
tem. After baseline subtraction, threshold lines were man-
ually established for each gene to cross the the log-linear
part of the fluorescence curves. Mean Ct values of the
duplicates were determined and transformed into relative
quantities.
Data analysis
Mann-Whitney U tests were performed with Statistica, ver-
sion 7 (Statsoft, Tulsa OK). The softwares geNorm™, ver-
sion 3.4 [30] and NormFinder [32] were used to calculate
stability of the candidate reference genes. The first,
geNorm, relies on the principle that the expression ratio of
two reference genes should be identical in all samples,
regardless of the experimental condition. It calculates the
expression stability measure (M) for the set of candidate
reference genes and by stepwise exclusion of the least sta-
ble gene in each step arrives to the the most stable pair of
reference genes. It provides also a way to estimate the best
number of required reference genes. NormFinder follows
a different approach: it calculates a stability value for each
individual candidate reference gene taking into account
separation of samples in the different groups that are of
interest in the specific area of research [32]. In this case,
the stability value is based on the combined estimate of
intra- and intergroup variation of gene expression.
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